Courses

spacer
Novel Drug Discovery (Molecular
Modeling & Computer Aided Drug Design)
spacer
Clinical Research, Pharma Research,
Pharmacovigilance & Clinical Data Management - CDM
spacer
SAS, Biostats & Project in Clinical Research
spacer
 

Features

 Job Oriented Certified Training
  Live Project Experience Certification
 Placement Assistance
 Reco Letters for Abroad
  Guidance for Journal Publications
  Resume Preparation Tips
  SMO Services
Bio Med Informatics

Our Candidates are
Employed with

Times of India

PHARMA FORTUNES
ITS STRENGTHS IN PHARMA TECHNOLOGY,AND A WEALTH OF SCIENTIFIC EXPERTISE,HAVE TAKEN THE INDIAN PHARMA SECTOR FROM STRENGTH TO STRENGTH. ANURADHA ANUPKUMAR EVALUATES OPPORTUNITIES IN THE SECTOR,AND FINDS WHY A CAREER IN PHARMA COULD BE JUST WHAT THE DOCTOR ORDERED

Ever since mankind was forced to come to terms with the fragility of human life, it has been consumed with conquering it. Is it any wonder then, that billions of dollars each year are pumped into the research and development of drugs to combat death, disease or aging?
Pharmacy has come a long way. After centuries of succumbing to plagues, poxes, or even the common cold, breakthroughs in the pharmaceutical industry have now equipped the world to deal with new strains that threaten a global pandemic every now and then, treat potentially terminal and ordinary illnesses perpetrated by changing lifestyles, or even just ensure good healthcare practices.
THE INDIAN PHARMACEUTICAL SECTOR
The Indian pharmaceutical industry is touted by many as one of the largest of the developing world, and has also gained a reputation for producing high-quality, low-cost generic drugs. “According to the McKinsey Report, Indian Pharma (Unlocking the potential of the Indian pharma market), the Indian pharmaceutical industry is growing in leaps and bounds with a CAGR of 13 per cent and is expected to grow at a CAGR of 16 per cent” reveals Pradeep Vaishnav, Senior Director, Aventis Pharma Limited (Group sanofiaventis), Mumbai, adding, “The industry is on the global radar now, more than ever, with India being viewed as the most sought-after destination for pharma activities, primarily research and development, and clinical research.” India’s prominent position in the world pharmaceutical sector can be credited, in part, to her mastery over pharma engineering technology, and reverse engineering of patented drug molecules.
Vaishnav goes on to add, “Many multinational, pharmaceutical companies are here, seeking India’s high level of scientific expertise and large pool of English-speaking talent. Besides, India still maintains its stronghold in contract manufacturing, which has further widened the scope of opportunities available in the pharmaceutical industry. Additionally, the concept of pharmaceutical retail chains has gained momentum in recent years, and has created numerous employment opportunities in the sector.”
PHARMA FORAYS The demand for a skilled workforce to power this sector, now presents unprecedented employment opportunities for aspirants.
Research and development
Research and development has several areas. According to Prabir Jha, Global Chief, HR, Dr Reddy’s Laboratories Ltd, Hyderabad, the area a student chooses within R&D, depends on his interest and passion. He says, “On one level, he can work in drug discovery, which is discovery of a new molecule. R&D can pertain to the development of generic products, analytical R&D, API (Active Pharmaceutical Ingredients) or bulk drugs R&D, or development of formulations, all of which have their own super specialisations.”
Sanjay Muthal, Managing Director, Nugrid Consulting predicts, “NCE or discovery research for a New Chemical Entity is a very promising area. There is a lot of reverse brain drain in this space, and we are able to attract people from the US and UK to pursue research here.” This area therefore offers an opportunity to work with the best minds from across the world.
“R&D can also deal with drug delivery, which can be in the form of a tablet, capsule or injection,” explains Professor R N Saha, Professor of Pharmacy, and Dean, Education Development Division, BITS-Pilani. He elaborates, “While meat is considered food, you cannot consume it in its raw form. You have to cook it. Similarly, you need to consume drugs through the correct delivery. There are also tremendous opportunities in this area.”

Clinical research
Screening of drugs involves testing new drugs or formulations on animal models, or conducting clinical research, which is essentially human testing. Prof Saha reveals, “Clinical research has recently witnessed a lot of international interest, with foreign companies coming to India to conduct clinical research.”
Regulation
Pharma is a regulated industry the world over, and professionals, who can manage regulatory affairs, are in high demand. “You can’t sell drugs like you sell anything else. Regulation is essentially a government affair, and it is an art and science to keep abreast of all the regulatory norms in the country,” declares Jha.
However, Prof Saha clarifies, “The regulatory sphere is not just a government sphere. For instance, if a company wants to market its product in the US, then they have to go by USFDA (United States Food and Drug Association) guidelines. For this, they will have advisors within the company, as well.”

 Top
 

BioMed in Media

Bio Specturum

Magazine

We are glad to say that BioSpectrum Magazine highlighted the name of BioMed Informatics, for its predominant role in the emerging technologies of Bioinformatics & Cheminformatics. Even Dr. Ashok IAS, Director of Biotechnology, Government of Andhra Pradesh, highlighted BioMed Informatics, in his interview with Pharmabiz Magazine in Mumbai. Excerpts enclosed herewith.

 
 
Pharmabiz.com

Magazine

AP state Biotech Policy to be redrafted to make it more industry friendly: Dr A Ashok Mumbai.The Government of Andhra Pradesh is committed to harness the benefits of biotechnology in order to make a positive contribution to the life of the common man.

 
Eenadu
Sakshi
Prajashakthi
Disclaimer: All the Logos & Registered Trademarks cited on this page are the Properties & Rights of the respective owners.
© 2000 BioMed Informatics, All Rights Reserved.